Precigen, Inc. (PGEN)
7.35
+0.18
(+2.51%)
USD |
NASDAQ |
Aug 25, 11:07
Precigen Total Liabilities (Quarterly) : 126.72M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 126.72M |
| March 31, 2026 | 118.39M |
| December 31, 2025 | 135.71M |
| September 30, 2025 | 129.40M |
| June 30, 2025 | 107.79M |
| March 31, 2025 | 113.33M |
| December 31, 2024 | 79.81M |
| September 30, 2024 | 28.10M |
| June 30, 2024 | 29.99M |
| March 31, 2024 | 37.83M |
| December 31, 2023 | 41.64M |
| September 30, 2023 | 43.01M |
| June 30, 2023 | 41.32M |
| March 31, 2023 | 57.41M |
| December 31, 2022 | 98.89M |
| September 30, 2022 | 116.71M |
| June 30, 2022 | 265.57M |
| March 31, 2022 | 261.73M |
| December 31, 2021 | 268.51M |
| September 30, 2021 | 245.65M |
| June 30, 2021 | 243.38M |
| March 31, 2021 | 232.19M |
| December 31, 2020 | 257.13M |
| September 30, 2020 | 277.63M |
| June 30, 2020 | 312.17M |
| Date | Value |
|---|---|
| March 31, 2020 | 317.44M |
| December 31, 2019 | 399.30M |
| September 30, 2019 | 376.48M |
| June 30, 2019 | 375.96M |
| March 31, 2019 | 375.04M |
| December 31, 2018 | 345.88M |
| September 30, 2018 | 424.97M |
| June 30, 2018 | 258.01M |
| March 31, 2018 | 324.24M |
| December 31, 2017 | 300.31M |
| September 30, 2017 | 345.08M |
| June 30, 2017 | 362.44M |
| March 31, 2017 | 365.77M |
| December 31, 2016 | 379.82M |
| September 30, 2016 | 397.17M |
| June 30, 2016 | 402.93M |
| March 31, 2016 | 287.60M |
| December 31, 2015 | 277.16M |
| September 30, 2015 | 260.26M |
| June 30, 2015 | 306.01M |
| March 31, 2015 | 166.64M |
| December 31, 2014 | 166.98M |
| September 30, 2014 | 158.66M |
| June 30, 2014 | 112.17M |
| March 31, 2014 | 115.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Geron Corp. | 300.40M |
| Elicio Therapeutics, Inc. | 23.39M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 170.30M |
| Shareholders Equity (Quarterly) | 43.58M |
| Debt to Equity Ratio | 2.257 |
| Current Ratio | 4.578 |
| Net Debt Paydown Yield | -0.91% |